Loading
Loading…
Loading…
Tender Value
₹9.0 L
EMD Value
Exempted
Closing Date
15 Oct 2026, 9:00 am
Published by the portal on this tender, for queries and grievance redressal.
MEDICINE
9943317
GEM/2026/B/8080671
Two Packet Bid
Tab Aspirin 150mg
Ambala, Haryana
Item wise evaluation
BOQ
11 documents required · 11 mandatory
3 yrs
₹4 L
₹9 L
30%
Exempted
Yes
24 Sept 2026
24 Sept 2026
16 Oct 2026
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | E D Brinozolamide 1 percent | 700 | Bott | mslp2@mh123 | 30 |
| 2 | E D Chloramphenicol 0 point 5 percent plus Dexamethasone | 300 | Bott | mslp2@mh123 | 30 |
| 3 | Dorzolamide 2 percent plus Timolol 0 point 5 percent bott of 5ml | 300 | Bott | mslp2@mh123 | 30 |
| 4 | E D Hyaluronate sodium 0 point 1 percent w v 5ml | 600 | Bott | mslp2@mh123 | 30 |
| 5 | Resp Formoterol 20mcg plus Budesonide 0 point 5mg | 31,800 | No | mslp2@mh123 | 30 |
| 6 | MDI Levosalbutamol 50mcg plus Ipratropium 20mcg | 1,900 | No | mslp2@mh123 | 30 |
| 7 | MDI Tiotropium Bromide 9 mcg | 180 | No | mslp2@mh123 | 30 |
| 8 | Inj Levocarnitine 500mg | 200 | Amp | mslp2@mh123 | 30 |
| 9 | Inj Ondansetron 2mg ml 4ml Inj | 40 | Amp | mslp2@mh123 | 30 |
| 10 | Lot Clobetesal 0 point 05 percent Salycyic Acid | 90 | Bott | mslp2@mh123 | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9943317.pdf
GEM_BID • 0.38 MB
25_pdf_2026-09-24-18-32-40_89034af382c9eb26aa5c6f357d0d9844.pdf
BOQ • 0.35 MB
boq_item_sample_file-52_2026-09-24-18-32-40_78e93a3c2b68a2d2e59dd3ea42ec10e7.csv
BOQ • 0.00 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .